Table 4.

The differentially expressed miRNAs in monocytes from patients with gastric cancer and in patients with breast cancer. n.a., not applicable. p-value indicates the statistical significance of the miRNA expression levels in samples from patients with gastric cancer versus those from patients with breast cancer.

namelog2 fold changechromosomal locationvalidated in ref.p-value
hsa-miR-539-5p3.281814q32.31[30]0.00180
hsa-miR-31342.69683p25.1[31]0.00311
hsa-miR-376a-5p2.696814q32.31[30]0.00311
hsa-miR-548e-5p2.696810q25.2[32]0.00311
hsa-miR-9332.43382q31.1[33]0.00377
hsa-miR-9903-12.4338n.a.n.a.0.00077
hsa-miR-9592.3342n.a.n.a.0.00148
hsa-miR-548ap-3p2.199315q25.3[34]0.00121
hsa-miR-12562.11181p36.12[32]0.00461
hsa-miR-15382.111816q22.1[35]0.00461
hsa-miR-877-3p2.11186p21.33[30]3.45×10−5
hsa-miR-31-3p−2.00369p21.3[30]0.00355
hsa-miR-378g−2.00361p21.3[36]0.00355
hsa-miR-5091−2.11064p15.33[37]1.22×10−10
hsa-miR-138-5p−2.136116q13[30]0.00239
hsa-miR-4781-3p−2.21011p32.3[38]0.00215
hsa-miR-195-3p−2.210117p13.1[30]0.00035
hsa-miR-365a-5p−2.210116p13.12[30]0.00283
hsa-miR-545-5p−2.2101Xq13.2[30]2.25×10−7
hsa-miR-6734-5p−2.21011p34.2[39]0.00035
hsa-miR-6802-3p−2.210119q13.42[39]0.00535
hsa-miR-3176−2.695516p13.3[31]0.00098
hsa-miR-4742-3p−2.69551q42.11[38]0.00008